These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17981034)

  • 21. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A combined molecular modeling study on gelatinases and their potent inhibitors.
    Xi L; Du J; Li S; Li J; Liu H; Yao X
    J Comput Chem; 2010 Jan; 31(1):24-42. PubMed ID: 19412908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
    Le Diguarher T; Chollet AM; Bertrand M; Hennig P; Raimbaud E; Sabatini M; Guilbaud N; Pierré A; Tucker GC; Casara P
    J Med Chem; 2003 Aug; 46(18):3840-52. PubMed ID: 12930146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent, selective pyrone-based inhibitors of stromelysin-1.
    Puerta DT; Mongan J; Tran BL; McCammon JA; Cohen SM
    J Am Chem Soc; 2005 Oct; 127(41):14148-9. PubMed ID: 16218585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of a highly selective gelatinase inhibitor generates active metabolite.
    Lee M; Villegas-Estrada A; Celenza G; Boggess B; Toth M; Kreitinger G; Forbes C; Fridman R; Mobashery S; Chang M
    Chem Biol Drug Des; 2007 Nov; 70(5):371-82. PubMed ID: 17927722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
    Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase.
    Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB
    Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
    Kilian M; Gregor JI; Heukamp I; Hanel M; Ahlgrimm M; Schimke I; Kristiansen G; Ommer A; Walz MK; Jacobi CA; Wenger FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 Dec; 75(6):429-34. PubMed ID: 17034997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
    Krüger A; Arlt MJ; Gerg M; Kopitz C; Bernardo MM; Chang M; Mobashery S; Fridman R
    Cancer Res; 2005 May; 65(9):3523-6. PubMed ID: 15867341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
    Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
    J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
    Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
    Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.
    Ayesa S; Lindquist C; Agback T; Benkestock K; Classon B; Henderson I; Hewitt E; Jansson K; Kallin A; Sheppard D; Samuelsson B
    Bioorg Med Chem; 2009 Feb; 17(3):1307-24. PubMed ID: 19124252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.
    Ledour G; Moroy G; Rouffet M; Bourguet E; Guillaume D; Decarme M; Elmourabit H; Augé F; Alix AJ; Laronze JY; Bellon G; Hornebeck W; Sapi J
    Bioorg Med Chem; 2008 Sep; 16(18):8745-59. PubMed ID: 18782669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
    Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
    Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of an orally active matrix metalloproteinase inhibitor.
    Yamamoto S; Nakatani S; Ikura M; Sugiura T; Nishita Y; Itadani S; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
    Bioorg Med Chem; 2006 Sep; 14(18):6383-403. PubMed ID: 16765051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
    Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
    Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.
    Lee KJ; Jang YH; Lee H; Yoo HS; Lee SR
    Eur J Neurosci; 2008 Jan; 27(2):334-42. PubMed ID: 18215232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
    Agamennone M; Campestre C; Preziuso S; Consalvi V; Crucianelli M; Mazza F; Politi V; Ragno R; Tortorella P; Gallina C
    Eur J Med Chem; 2005 Mar; 40(3):271-9. PubMed ID: 15725496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.